Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30

$6.83+0.08 (+1.19%)

Close on Nov 12, 2026Market cap $105.58MP/E –Yield –

Satellos Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Satellos Bioscience's enterprise value was $88.72M on Nov 11, 2026, against $19.23M a year earlier.

Period	Period end	Value	Change
2026	Nov 11, 2026	$88.72M	+448.6%
2025	Dec 31, 2025	$16.17M	–

See a number that looks wrong?